Am J Hematol 2019 Apr 04
Low-dose vemurafenib in hairy cell leukemia patients with active infection.
Related Questions
What would you consider as contra-indications to Cladribine?
New answer by Medical Oncologist at Ohio State University (March 27, 2022)
This is an outstanding question and there are a few reasons to consider treatments other than cladribine or a chemotherapy-free approach. I have considered and used alternativ...